Infectious disease research, prevention, and patient care are well established traditions at the NYU School of Medicine and Bellevue Hospital, and we continue to build on those traditions...
"Dendritic Cell-Targeted Lentiviral Vectors for HIV-1 Vaccine Development"
Thomas Norton, MD
Faculty, NYU School of Medicine
Friday, September 12, 2014, 8:00am
NYU Langone Medical Center | Smilow Seminar Room
Julie Gerberding, MD, MPH
President, Merck Vaccines
Former Director, U. S. Centers for Disease Control and Prevention
October 2, 2014 | 4pm, Smilow Seminar Room | NYU Langone Medical Center